CNR2 and Alzheimer disease: Experimental studies demonstrate that neuroglial activation occurs in mouse models of AD, accompanied by increased CB2 expression and upregulation of pro-inflammasome proteins, which contribute to neuronal damage (Bie et al., 2018).